Article Details

Frasers Group launches share buyback, AstraZeneca upbeat on Farxiga approval

Retrieved on: 2021-05-04 06:45:00

Tags for this article:

Click the tags to see associated articles and topics

Frasers Group launches share buyback, AstraZeneca upbeat on Farxiga approval. View article details on hiswai:

Excerpt

AstraZeneca said that Farxiga has been approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and ...

Article found on: www.sharecast.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up